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Current methods for detecting H2O2 in-
volve fluorometric assays, such as Amplex 
Red (Thermo Fisher Scientific) or ferrous 
oxidation of xylenol orange [12]. These as-
says are very sensitive but unfortunately are 
susceptible to contamination by other body 
fluids, particularly blood, and are not rou-
tinely available in clinical laboratories, much 
less as a POC tool. Electrochemical and op-
tical-based probes have also been developed 
[13–16]. However, both techniques require 
additional equipment and have major limita-
tions. Electrochemical systems are affected 
by electrolytes and debris in the drained flu-
id that are difficult to control for, and opti-
cal methods have limited depth of penetra-
tion, particularly in turbid fluid and in fluid 
that contains blood. A reliable, low-cost sen-
sor such as ultrasound (US) that could detect 
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H
ydrogen peroxide (H2O2) is a 
valuable biomarker of oxidative 
stress that has been associated 
with many disease states includ-
ing cancer, diabetes, acute respiratory dis-
tress, and infection [1–10]. For example, H2O2 
production as a component of leukocyte oxi-
dative burst is a key defense mechanism 
against infection, with stimulated neutrophils 
producing up to 65 μM of extracellular H2O2 
in solution [11]. Because infected fluid collec-
tions are rich with neutrophils and other leu-
kocytes, we hypothesized that elevated levels 
of H2O2 in body fluids would indicate that the 
fluid is infected. Therefore, detection of this 
reactive oxygen species at bedside could serve 
as a valuable point-of-care (POC) tool to help 
manage patients with abnormal fluid collec-
tions [1, 5–7].
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OBJECTIVE. Hydrogen peroxide (H2O2) plays a key role in neutrophil oxidative defense 
against infection. Catalase-containing silica nanoshells are nanoparticles that generate O2 
microbubbles imaged with ultrasound in the presence of elevated H2O2. We aimed to deter-
mine whether ultrasound-detectable O2 microbubbles produced by catalase-containing silica 
nanoshells can determine whether fluid collections drained from patients are infected. 
SUBJECTS AND METHODS. During this HIPAA-compliant, institutional review 
board–approved study, 52 human fluid samples were collected from clinically required im-
age-guided percutaneous drainage procedures. Catalase-containing silica nanoshells were 
added to the fluid samples during imaging in real time using a Sequoia-512 15L8-S linear 
transducer (Siemens Healthcare). Production of detectable microbubbles was graded subjec-
tively as negative (noninfected) or positive (infected) with low, moderate, or high confidence 
by a single observer blinded to all clinical data. The truth standard was microbiology labo-
ratory culture results. Performance characteristics including ROC curves were calculated. 
RESULTS. Microbubble detection to distinguish infected from noninfected fluids was 
84% sensitive and 72% specific and offered negative and positive predictive values of 89% 
and 64%, respectively. The AUC was 0.79. Six of nine false-positive samples were peritoneal 
fluid collections that were all collected from patients with decompensated cirrhosis. 
CONCLUSION. The presence of elevated H2O2 indicated by microbubble formation in 
the presence of catalase-containing silica nanoshells is sensitive in distinguishing infected 
from noninfected fluids and offers a relatively high negative predictive value. False-positive 
cases may result from noninfectious oxidative stress. Catalase-containing silica nanoshells 
may constitute a novel point-of-care test performed at time of percutaneous drainage, poten-
tially obviating placement of drains into otherwise sterile collections and minimizing risk of 
secondary infection or other complication. 
Malone et al.
Ultrasound Detection of Hydrogen Peroxide in Fluid Collections
Gastrointestinal Imaging
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H2O2 at the bedside as a POC tool would be 
of benefit, particularly because it is common-
ly used to guide needle placement.
Previous reports describe nanoporous par-
ticles containing the enzyme catalase, which 
is capable of catalyzing H2O2 into oxygen 
(O2) and water both in vitro and in vivo, 
while protecting the enzyme from degrada-
tion [17, 18]. On exposure to US, the released 
O2 forms microbubbles that are detectable 
with standard US equipment (Fig. 1). Specif-
ically, the use of these particles allowed the 
detection of H2O2 released by activated neu-
trophils in vitro and produced microbubbles 
detectable in vivo when injected into infec-
tious collections within rats [17].
Minimally invasive, image-guided diag-
nostic and therapeutic procedures are now a 
routine component of modern medicine, and 
ultrasound is commonly used to guide per-
cutaneous drainage procedures of fluid col-
lections suspected to be infected [19, 20]. In 
this study we aimed to assess whether ultra-
sound can detect elevated levels of H2O2 in 
fluids aspirated from patients as a biomarker 
for infected fluid. Catalase-containing silica 
nanoshells were added to the aspirated fluid 
ex vivo to attempt to generate ultrasound-de-
tectable O2 microbubbles in the presence of 
H2O2. We hypothesized this technique could 
help rule out infection and eliminate the 
need to obligatorily place a drainage catheter 
into an otherwise sterile (noninfected) col-
lection, thus providing a practical POC test 
that could be easily incorporated into routine 
clinical practice.
Subjects and Methods
Chemicals Used
Glycol chitosan (GC), deoxycholic acid (DA), 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC), N-Hydroxysuccinimide (NHS), catalase, 
tetraethyl orthosilicate (TEOS), and ammonium 
hydroxide (NH4OH) were all purchased from an 
outside supplier and were used without further 
purification. Deoxycholic acid–conjugated glycol 
chitosan (DA-GC) and catalase-containing silica 
nanoshells were prepared and characterized in our 
laboratory as described later in this section.
Synthesis and Characterization of Deoxycholic 
Acid–Conjugated Glycol Chitosan 
GC was modified with hydrophobic deoxy-
cholic acid moieties to serve two purposes. First, 
this amphiphilic polymer was used to physically 
crosslink the nanogel through hydrophobic inter-
actions. Second, the positive charge on the poly-
meric backbone allowed coating of the nano-
gel particles with silica. GC (500 mg, 2.4-mmol 
monomer) was dispersed in ultrapure water (50 
mL) and stirred at 40°C until it dissolved com-
pletely. The resulting clear solution was then 
cooled to room temperature. DA (163 mg, 0.42 
mmol), EDC (350 mg, 3.9 mmol), and NHS (450 
mg, 3.9 mmol) were added to the solution, and the 
resulting mixture was stirred at room temperature 
for 20 hours. Ethanol (25 mL) was then added to 
reach 33% by volume. The final mixture was di-
alyzed against water for 24 hours using a cellu-
lose ester dialysis membrane (Spectra/Por Float-
A-Lyzer G2, Spectrum Laboratories; molecular 
weight cut-off = 3.5–5 kDa). Water was replaced 
four times during dialysis. The resulting solution 
was freeze-dried to yield 700 mg of DA-GC as a 
white powder. The degree of substitution of DA-
GC, defined by the number of deoxycholic acid 
moieties conjugated to the polymer backbone per 
100 monomers was determined by 1H nuclear MR 
spectroscopy (Unity Inova 500 MHz spectrome-
ter, Varian). Peaks corresponding to the protons 
of the three methyl groups of the deoxycholic 
acid (0.72, 0.94, and 1.01 ppm) were integrated 
and compared with the peaks corresponding to 
the protons of the monomer (3.4–4.0 ppm) to give 
a mean substitution ± SD of 18% ± 2.6% (Fig. S1, 
a supplemental figure, can be viewed in the AJR 
electronic supplement to this article, available at 
www.ajronline.org.).
Formulation and Characterization of Catalase-
Containing Silica Nanoshells
DA-GC (12 mg) was dispersed in 6 mL of 1× 
phosphate-buffered saline (PBS) and heated to 70°C 
until it completely dissolved. The DA-GC solution 
was then cooled to room temperature, and 60 mg 
catalase (270 kU) was added. Nanogels were pro-
duced through direct high-pressure homogenization 
in a low-volume microfluidizer (LV1, Microfluidics) 
equipped with a cooling coil using three to nine cy-
cles at 13,000 psi (89,632 kPa). Both the coil and tray 
were cooled with ice to avoid thermal denaturation 
of catalase. The mean hydrodynamic diameter of the 
formed nanogels was measured with dynamic light 
scattering (DLS) using the Zetasizer ZS nano-sizing 
system (Malvern Nano ZS, Malvern Instruments) 
and with transmission electron microscopy (TEM) 
(TecnaiG2 Spirit BioTWIN microscope, FEI) using 
negative staining with 2% uranyl acetate in water.
An aqueous solution of 1 M NH4OH (2.6 mL) and 
TEOS (370 μL) were added to the nanogel suspen-
sion (6 mL), and the resulting mixture was stirred for 
16 hours at room temperature. The suspension was 
then centrifuged at 500 × g to remove any large silica 
aggregates, and the supernatant containing the cata-
lase-containing silica nanoshells was collected.
The mean hydrodynamic diameter and poly-
dispersity index of the resulting catalase-contain-
ing silica nanoshells were measured by DLS while 
their concentration and size distribution were 
measured with the qNano Gold system (Izon Sci-
ence), a tunable resistive pulse sensing (TRPS) in-
strument, using the NP300 nanopore and corre-
sponding calibration beads. Catalase-containing 
silica nanoshells were further characterized by 
TEM using a 20-μL dilute sample on a carbon-
formvar grid stained with 2% uranyl acetate neg-
ative staining solution. Finally, catalase activity 
was measured using the Amplex Red Catalase As-
say Kit (Thermo Fisher Scientific).
In Vitro Ultrasound-Based Detection of H2O2 
With Catalase-Containing Silica Nanoshells
The ability of catalase-containing silica 
nanoshells to generate microbubbles when exposed 
to H2O2 was assessed in vitro by suspending 1010 
nanoparticles in 3 mL 1× PBS in a 3-mL plastic 
transfer pipette bulb containing 0.04 M sodium cho-
late to stabilize formed microbubbles. The transfer 
pipette was placed inside a tissue-mimicking sam-
ple holder composed of 1% agarose and 0.5% corn-
starch in a 37°C bath and allowed to equilibrate. 
Fig. 1—Illustration depicts microbubble generation and detection when nanoparticles containing catalase are 
exposed to H2O2 during ultrasound imaging. Silica shell protects catalase from endogenous proteases while 
remaining porous to small molecules such as H2O2. After being converted to O2 by catalase, O2 microbubbles 
are generated and detected by ultrasound.
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Small aliquots of H2O2 were added to reach final 
concentrations of 10, 100, and 1000 μM using a 
transfer pipette. All solutions were introduced with 
the pipette tip positioned at the most nondependent 
aspect of the sample to prevent air from being in-
troduced into the sample, which could be mistak-
en for de novo microbubbles. Samples were imaged 
using a clinical ultrasound scanner (Siemens Acu-
son Sequoia 512, Siemens Healthcare) equipped 
with a 15L8 transducer and contrast pulsing se-
quence imaging mode using a 7-MHz central trans-
mit frequency and a mechanical index (MI) of 0.25 
at 16 frames/s. The contrast pulsing sequence and 
B-mode images reconstructed from the same back-
scattered signal were displayed side by side and in 
cine loops recorded from before and for 1 min af-
ter the addition of H2O2. ImageJ software (National 
Institutes of Health) was used to quantify the ultra-
sound signal of generated O2 microbubbles, which 
were detected within seconds of adding the H2O2. 
Ellipsoidal ROIs were drawn on the gray-scale US 
image and the log-compressed mean video inten-
sity was measured from a mean of 40 frames ac-
quired before and after the addition of H2O2. The 
difference in video intensity before and after add-
ing H2O2 was recorded. Each H2O2 concentration 
experiment was done in triplicate.
Patient Population
We obtained approval from the institutional re-
view board of the University of Texas Southwestern 
Medical Center, and the requirement of informed 
consent was waived. All corresponding fluids and 
clinical data were collected in a manner compliant 
with HIPAA from a single institution between Feb-
ruary 2016 and January 2017. Any patient who had a 
fluid collection diagnosed on ultrasound or CT and 
was scheduled to undergo aspiration or drainage of 
the collection or who was scheduled for a therapeutic 
paracentesis or thoracentesis as part of that patient’s 
clinical care was included. Paracentesis and thora-
centesis fluids were included to balance the number 
of noninfected and infected samples to adequately 
power the study. Collected fluid samples were as-
signed a unique research identification number and 
transferred on ice to the laboratory, where they were 
stored at –80°C in a tightly capped container to ar-
rest H2O2 catalysis by free catalytic enzymes or 
WBC peroxidases until later processing could be 
completed. The time from aspiration to freezing was 
1 hour or less. Corresponding clinical data recorded 
included major medical and surgical comorbidities, 
clinical presentation, body location of the drained 
fluid, clinical laboratory findings including Gram 
stain, cell count and differential, and culture results. 
No clinical data were revealed until all H2O2 ultra-
sound detection experiments were completed and re-
corded. Samples were excluded from analysis if they 
lacked proper identification or clinical data to deter-
mine infectious status.
Evaluation of Fluid Collections
A catalase-containing silica nanoshell suspen-
sion containing 2.95 × 108 nanoshells/mL was pre-
pared. Fluid samples were thawed, and those that 
were viscous or turbid were centrifuged and the 
supernatant tested. All H2O2 detection ultrasound 
imaging experiments were performed at 37°C with 
each sample placed in a 3-mL transfer pipette as 
was done for nanoshell characterization. Because 
samples can contain very low to high concentra-
tions of H2O2, we performed two experiments with 
each sample in triplicate to maximize detection. In 
the first experiment, 20 μL of the catalase-contain-
ing silica nanoshell suspension were added to 0.7 
mL of the sample. In the second, 20 μL of the sam-
ple were added to 0.7 mL of the suspension.
Ultrasound imaging was performed as was done 
for nanoshell characterization, and cine record-
ings were acquired immediately before and for 2–3 
minutes after combining catalase-containing silica 
nanoshells with the fluid sample. De novo formation 
of microbubbles was defined as formation of new 
echogenic foci within the solution confirmed to be 
microbubbles by observing their rise toward the sam-
ple surface and their disappearance when exposed to 
high-power US (MI = 1.9). All fluid samples were 
processed and judged subjectively as either positive 
or negative for de novo microbubble formation by a 
single operator who was blinded to all clinical data. 
For samples deemed to be positive, a low, moderate, 
or high confidence level was also recorded.
Reference Standard
The classification of fluid samples as infected or 
noninfected was determined by a single radiologist 
who was not aware of the ultrasound results. All 
but four fluid samples were cultured for pathogens. 
Fluid samples were considered infected when cul-
ture was positive for microorganisms. Of the four 
collections not cultured, two were recorded as in-
fected. One patient had a suspected liver abscess on 
imaging and a positive blood culture. The other had 
a symptomatic postoperative splenic bed fluid col-
lection, and the patient improved after drainage and 
antibiotic treatment. Of the two samples recorded 
as noninfected, one was drained from a patient with 
a symptomatic renal cyst requiring aspiration, and 
the other was ascitic fluid from a patient with symp-
tomatic large-volume ascites. A 2 × 2 table was con-
structed for infected versus noninfected fluids and 
positive versus negative microbubble formation. 
Sensitivity, specificity, and positive and negative 
A
Fig. 2—Illustrations depict process of creating catalase-containing silica nanoshell.
A, Chemical reaction used to modify glycol chitosan (GC) with deoxycholic acid (DA) through 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and N-Hydroxysuccinimide (NHS) coupling reaction. 
B, Schematic representation of two-step process to first formulate catalase-loaded nanogels and then silica-
coated nanoshells. TEOS = tetraethyl orthosilicate.
B
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predictive values were then calculated, and an ROC 
curve was constructed using the three confidence 
levels using Excel (version 16.15, Microsoft).
Results
Catalase-containing silica nanoshells were 
manufactured by producing porous DA-GC 
nanogels that were thereafter loaded with cat-
alase and finally coated with silica (Fig. 2). 
The nanoshells had a hydrodynamic diameter 
of 177 nm and a polydispersity index of 0.293 
as measured by DLS (Fig. 3A). One millili-
ter of catalase-containing silica nanoshell sus-
pension contained 2.95 × 1010 nanoparticles 
as measured by TRPS (Fig. 3B). The parti-
cle size was further confirmed by TEM (Fig. 
3C). Catalase activity of catalase-containing 
silica nanoshells was 43,650 U/mL (97% of 
the activity of the starting catalase before en-
capsulation), confirming the nondestructive 
catalase-containing silica nanoshell formu-
lation process. Consequently, the 2.95 × 108 
nanoshells/mL suspension used to test the 
samples for the presence of H2O2, was capa-
ble of catalyzing 436.5 μM of H2O2 per min-
ute. Using graded concentrations of H2O2, 
microbubble formation was detectable by ul-
trasound when catalase-containing silica 
nanoshells were bathed in 10 μM of H2O2, and 
the number of microbubbles and correspond-
ing video intensity increased with increasing 
H2O2 concentration (Fig. 4).
Samples from 52 patients were collected 
from drainage or aspiration procedures per-
formed as part of their clinical care, 19 of 
which were classified as infected and 33 as 
not infected (Table S2, which can be viewed 
in the AJR electronic supplement to this ar-
ticle, available at www.ajronline.org.). When 
samples were positive for microbubble for-
mation, microbubbles formed within sec-
onds of the addition of the catalase-con-
taining silica nanoshells. Figure 5 shows a 
representative case of a 44-year-old wom-
an who presented with abdominal pain after 
hysterectomy and hemicolectomy and had a 
rim-enhancing collection within the pelvis 
on CT. Her fluid sample, which was positive 
for Escherichia coli, produced microbubbles 
on ultrasound. Results of microbubble gen-
eration from infected versus noninfected flu-
id samples are summarized in Table 1. Of 
the 19 infected samples, 16 produced detect-
able microbubbles with confidence levels of 
low (n = 3), moderate (n = 8), or high (n = 
5), resulting in a sensitivity of 84% when all 
confidence levels are combined. Of the 33 
noninfected samples, 24 did not generate mi-
crobubbles, resulting in a specificity of 73%. 
The negative and positive predictive values 
were 89% and 64%, respectively. The area 
under the ROC curve was 0.79 (Fig. 6).
Three false-negative results were encoun-
tered, one from a sample that was not cultured 
but that was labeled as infected on clinical 
grounds (presumed liver abscess on imaging 
in a patient with positive blood cultures). The 
second was from an abdominal fluid collec-
tion that grew Clostridium perfringens and 
other mixed gastrointestinal flora. The third 
was from a renal cyst that grew E. coli.
Of the nine noninfected samples that gen-
erated microbubbles, six were ascites sam-
ples aspirated from patients with decom-
pensated cirrhosis. Of the remaining three 
samples that had a negative culture, two had 
elevated WBC count: One was aspirated 
from a peripancreatic fluid collection result-
ing from acute pancreatitis and complicated 
by pseudocyst formation, and the other was a 
right upper quadrant collection after partial 
hepatectomy complicated by bile leak. The 
third sample was chylous ascites following 
retroperitoneal lymph node dissection.
Discussion
Catalase-containing nanoshell particles 
help maintain catalase activity by retaining 
A
Fig. 3—Characteristics of nanogels and nanoshells used.
A, Size distribution of catalase-loaded nanogels (dashed line) and nanoshells (solid line) as measured by dynamic light scattering. 
B, Size distribution and count of nanoshells as measured by tunable resistive pulse sensing. 
B
(Fig. 3 continues on next page)
TABLE 1: Summary of Microbubble Generation From Infected and 
 Noninfected Fluids
Microbubble Generation Infected Noninfected Total
Yes 16 9 25
No 3 24 27
Total 19 33 52
Note—Sensitivity = 84%, specificity = 73%, positive predictive value = 64%, negative predictive value = 89%.
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the enzyme within a hard nanoporous shell, 
which allows free access to small water sol-
uble molecules, such as H2O2, while protect-
ing it from macromolecules, such as endoge-
nous proteases and antibodies. When added to 
solutions of H2O2, the catalase breaks down 
H2O2 into O2 and water. O2 microbubble nu-
cleation and detection can then be achieved 
using clinically available ultrasound systems 
[17, 18]. Although catalase-containing sili-
ca nanoshells were produced using a differ-
ent formulation than reported previously, they 
also generated O2 microbubbles at H2O2 con-
centrations of 10 μM and above [17, 18].
In this first study geared toward translat-
ing this technique to the clinic, we hypoth-
esized that H2O2 elevation could serve as a 
biomarker to distinguish infected from non-
infected fluid collections. We were not sur-
prised that 16 of the 19 infected collections 
generated microbubbles detectable by US 
when catalase-containing silica nanoshells 
were added ex vivo because inflammation, 
and particularly infection, recruits inflam-
matory cells that are known to release H2O2 
[21]. Of the three false-negative results, one 
collection in the liver was not cultured and 
was presumed to be infected on the basis of 
clinical grounds, one culture was positive 
probably because of contamination, and the 
third was a renal cyst aspirate that grew E. 
coli. Although centrifuging samples to re-
move debris may have affected microbubble 
formation or detection (or both), we doubt 
it had an impact because imaging was done 
with microbubble-only imaging that sub-
tracts signal from nonmicrobubble scatterers 
and because H2O2 is a small water soluble 
molecule that would reside in the superna-
tant that was analyzed when samples were 
centrifuged. High viscosity, which would re-
quire higher ultrasound pressure to nucle-
ate microbubbles, could also have had an 
impact, but we do not think viscosity was 
a factor in this study because it would in-
crease the false-negative rate, and only three 
false-negative results were seen in 19 sam-
ples. H2O2 levels also could have been af-
fected by freezing and thawing of samples 
for analysis. Although we doubt that H2O2 
levels could increase before analysis to yield 
a false-positive test, it is not clear whether 
the three false-negative samples were affect-
ed by endogenous catalase and WBC peroxi-
dases that could have consumed the H2O2 or 
whether storage at –80°C affected H2O2 lev-
els. We doubt that freezing had an effect be-
cause a previous study by Bortolin et al. [22] 
found that biologic samples were affected 
after freeze-thaw at –20°C but not at –80°C 
as was done in our study. Moreover, H2O2 is 
a small, water-soluble molecule that should 
not be affected by freezing. In the next study, 
we plan to perform the ultrasound test on 
aspirated fluid at the bedside, immediately 
after collection.
Although a negative result had at least 
89% predictive value, positive results were 
less predictive; however, abnormally elevat-
ed levels of H2O2 could be used to explain 
other conditions in an otherwise sterile col-
lection, such as inflammation or oxidative 
stress, in the proper clinical setting. Six of 
the nine false-positive results were from as-
cites samples aspirated from patients with 
decompensated liver disease, and two were 
from collections resulting from conditions 
known to cause significant regional inflam-
mation (acute pancreatitis, bile peritonitis). 
It is intriguing to speculate that in patients 
with decompensated liver function from cir-
rhosis specifically, H2O2 levels could be el-
evated as a result of oxidative stress rather 
than infection, which has been implicated in 
increasing peritoneal permeability leading 
to ascites [23].
This method of detecting elevated levels 
of H2O2 at the bedside can be easily incor-
porated into interventional procedures, par-
ticularly because ultrasound is portable and 
commonly used to guide needle aspiration 
and drainage catheter placement. The most 
rapid and available method to predict wheth-
er a fluid is infected is based on results of 
a Gram stain performed on fluid immediate-
ly after aspiration, which may take up to 30 
minutes and require close coordination with 
the microbiology laboratory. The method 
presented here yielded a higher specificity 
and comparable sensitivity for detection of 
infected fluids than a method used by Ketai 
et al. [19] that incorporated results of a Gram 
stain, WBC count in the fluid, and whether 
fluid was visually purulent [19]. In contrast, 
detection of elevated levels of H2O2 would 
be available immediately, acting as a POC 
test in the proper clinical setting. Although 
a host of biosensors have been developed to 
detect infectious diseases, they require sam-
ple preparation, ability to handle heteroge-
neous and complex fluids, specific hardware 
development, and, equally challenging, im-
plementation into the clinical infrastructure 
and workflow [24].
The decision to place a drainage cathe-
ter into a collection presumed to be infected 
because of the presence of H2O2 is support-
ed by the relatively high negative predictive 
value achieved in this study. Should this re-
C
Fig. 3 (continued)—Characteristics of nanogels and 
nanoshells used.
C, Transmission electron microscopic pictures of 
nanogels (top) and nanoshells (bottom).
A
Fig. 4—Increasing ultrasound signal intensity from 
O2 microbubbles generated from catalase-containing 
silica nanoshells correlated with H2O2 concentration. 
A, Video intensity measured at various 
concentrations of H2O2. 
(Fig. 4 continues on next page)
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sult be supported by a larger study, it would 
obviate the placement of drains into other-
wise sterile collections, thus minimizing 
risk of contamination, secondary infection, 
or other complications. This advantage is 
particularly pertinent for drainage of sub-
diaphragmatic collections, which carry the 
risk of traversing the pleura with a large 
drainage catheter [25]. Nearly half of flu-
id collections after abdominal surgery are 
not infected [26]. Although placing a drain-
age catheter over simple aspiration of ster-
ile pancreatic collections yielded no clini-
cal benefit, long-term catheter placement 
resulted in bacterial colonization in more 
than 50% of cases [27]. Further benefit of 
not draining sterile collections is that half 
of collections that develop after pancreatic 
surgery are asymptomatic or resolve spon-
taneously [28]. Therefore, there is clear 
clinical benefit in recognizing which fluid 
collections need further drainage.
Whether this POC test could be used to 
guide drainage decisions will require addi-
tional prospective clinical studies. We an-
ticipate that in the initial phase of develop-
ment, our approach can be incorporated as 
an ex vivo test to avoid regulatory hurdles 
and biologic safety concerns about catalase-
containing silica nanoshells, speeding trans-
lation. In the long term, catalase-containing 
silica nanoshells may be able to be incorpo-
rated into the aspiration needle to test for the 
presence of H2O2 by ultrasound in vivo.
Our study had several limitations. First, 
three of the 52 samples were not cultured 
and assignment as infected or not infect-
ed was made on a clinical basis. Further, 
some samples were collected from patients 
during the course of their illness when an-
tibiotic therapy or other interventions may 
have been initiated, potentially affecting 
the utility of culture results [29]. Regardless 
of whether antibiotic therapy was initiated, 
particularly in septic patients, our test only 
evaluates for the presence of H2O2 [30]. Be-
cause H2O2 is naturally catalyzed in extra-
cellular fluid and plasma and eliminated in 
urine, the continued presence of H2O2 after 
intervention, which renders our test positive, 
suggests continued H2O2 production and 
therefore continued inflammation. Second, 
only one observer assessed the production of 
microbubbles on ultrasound after the addi-
Fig. 4 (continued)—Increasing ultrasound signal intensity from O2 microbubbles generated from catalase-containing silica nanoshells correlated with H2O2 concentration. 
B, Representative images of O2 microbubbles (arrows) generated at 10 (left), 100 (middle), and 1000 (right) µM of H2O2.
B
A
Fig. 5—44-year-old woman with abdominal pain after hysterectomy and hemicolectomy. 
A, CT scan obtained before drainage procedure shows rim-enhancing fluid collection in left lower quadrant (arrows). Culture of drained fluid grew Escherichia coli. 
B, On contrast mode (left) and B-mode (right) ultrasound, catalase-containing silica nanoshells added to aliquot of this collection resulted in generation of O2 
microbubbles (arrows) from pathophysiologic levels of H2O2.
B
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Fig. 6—ROC curve (solid 
line) from catalase-
containing silica 
nanoshell microbubble 
generation in 
distinguishing infected 
from noninfected fluids. 
AUC = 0.79. Dotted line 
denotes AUC of 0.5. 
tion of catalase-containing silica nanoshells 
in this pilot study. Future studies will need 
to evaluate interobserver variability. Third, 
though microbubble production in the pres-
ence of H2O2 has been well documented in 
the literature, and in this study quantifica-
tion of H2O2 levels in the fluid samples was 
not possible [17, 18, 31]. Amplex Red assay 
was unreliable because of several factors 
including biologic complexity of aspirate, 
sample heterogeneity, and contamination by 
blood that interferes with the fluorescence 
readout [32]. Electrochemical methods for 
H2O2 quantification were also significant-
ly limited by the heterogeneous complex 
biologic samples that had high background 
electrical signal, in part because of the vari-
ability in electrolyte content.
Conclusion
Elevated H2O2, as shown by ultrasound 
detection of O2 microbubble formation in 
the presence of catalase-containing silica 
nanoshells, is sensitive for distinguishing in-
fected from noninfected fluids and may serve 
as a tool in detecting high oxidative stress. 
Most importantly, lack of microbubble detec-
tion carried an 89% negative predictive val-
ue for ruling out infection, which may help 
avoid placing a draining catheter into an oth-
erwise noninfected collection, minimizing 
unnecessary cost and risk. With formulation 
and procedure optimization, this test may be-
come more predictive. The proposed bedside 
technique is advantageous over fluorescence 
or electrochemical methods for H2O2 detec-
tion because it uses conventional US images 
as its readout. Although this study had limi-
tations, our results are encouraging and help 
justify the optimization of this POC proce-
dure to facilitate a larger prospective study 
to assess potential impact on patient manage-
ment decisions.
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